LBEL description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

LBEL

Ventura International Ltd.

L'BEL DIVINE Polvos compactos doble uso FPS 15 edición de lujo dorado/Double use compact SPF 15 gold deluxe edition


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Drug Facts

Active Ingredients

TITANIUM DIOXIDE (6.2393%), ZINC OXIDE (4.9%), OCTINOXATE (3.0%)

Purpose

Sunscreen

LBEL Uses

  • Helps prevent sunburn

Warnings

  • Skin Cancer / Skin Aging Alert; Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging.
  • For external use only.
  • Do not use on damage or broken skin.
  • When using this product keep out of eyes. Rinse with water to remove.
  • Stop use and ask a doctor if rash occurs.
  • Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • Apply liberally and evenly 15 minutes before sun exposure.
  • Children under 6 months of age: Ask a doctor.
  • Reapply at least every 2 hours.
  • Use a water resistant sunscreen if swimming or sweating.

LBEL Other information

  • Protect the product in this container from excessive heat and direct sun.

Inactive ingredients

MICA, POLYMETHYLSILSESQUIOXANE, HDI/TRIMETHYLOL HEXYLLACTONE CROSSPOLYMER, DIMETHICONE, MAGNESIUM STEARATE, TRIMETHYLSILOXYSILICATE, ISOSTEARYL NEOPENTANOATE, HYDROGEN DIMETHICONE, TOCOPHERYL ACETATE, PHENOXYETHANOL, ALUMINA, TRIETHOXYCAPRYLYLSILANE, PARFUM (FRAGRANCE), CAPRYLYL GLYCOL, CERAMIDE 3, CHLORPHENESIN. MAY CONTAIN: CI 77492 (IRON OXIDES), CI 77491 (IRON OXIDES), CI 77891 (TITANIUM DIOXIDE ), CI 77499 (IRON OXIDES).

US: Dist by Ventura Int Ltd. DBA Belcorp USA, San Francisco, CA 94111.

PRINCIPAL DISPLAY PANEL - 10 g Cartridge Box - Claire 1-2-3

DIVINE

Polvos compactos doble uso FPS 15 edición de lujo dorado

Double use compact SPF 15 gold deluxe edition

10 g e (.35 oz.)

L'BEL

LBEL

PRINCIPAL DISPLAY PANEL - 10 g Cartridge Box - Claire 4

DIVINE

Polvos compactos doble uso FPS 15 edición de lujo dorado

Double use compact SPF 15 gold deluxe edition

10 g e (.35 oz.)

L'BEL

LBEL

PRINCIPAL DISPLAY PANEL - 10 g Cartridge Box - Medium 5

DIVINE

Polvos compactos doble uso FPS 15 edición de lujo dorado

Double use compact SPF 15 gold deluxe edition

10 g e (.35 oz.)

L'BEL

LBEL

PRINCIPAL DISPLAY PANEL - 10 g Cartridge Box - Medium 6

DIVINE

Polvos compactos doble uso FPS 15 edición de lujo dorado

Double use compact SPF 15 gold deluxe edition

10 g e (.35 oz.)

L'BEL

LBEL

PRINCIPAL DISPLAY PANEL - 10 g Cartridge Box - Medium 7

DIVINE

Polvos compactos doble uso FPS 15 edición de lujo dorado

Double use compact SPF 15 gold deluxe edition

10 g e (.35 oz.)

L'BEL

LBEL

PRINCIPAL DISPLAY PANEL - 10 g Cartridge Box - Obscure 8-9

DIVINE

Polvos compactos doble uso FPS 15 edición de lujo dorado

Double use compact SPF 15 gold deluxe edition

10 g e (.35 oz.)

L'BEL

LBEL

LBEL

Titanium Dioxide, Zinc Oxide, and Octinoxate POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:14783-056
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
titanium dioxide 0.062393 g
Zinc Oxide Zinc oxide 0.049 g
OCTINOXATE OCTINOXATE 0.03 g

Inactive Ingredients

Ingredient Name Strength
MICA
DIMETHICONE
MAGNESIUM STEARATE
ISOSTEARYL NEOPENTANOATE
.ALPHA.-TOCOPHEROL ACETATE
PHENOXYETHANOL
ALUMINUM OXIDE
TRIETHOXYCAPRYLYLSILANE
CAPRYLYL GLYCOL
CERAMIDE 3
CHLORPHENESIN
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
RED (Rose)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:14783-056-01 10 in 1 CARTRIDGE
2 NDC:14783-056-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-05-27


LBEL

Titanium Dioxide, Zinc Oxide, and Octinoxate POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:14783-057
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
titanium dioxide 0.062393 g
Zinc Oxide Zinc oxide 0.049 g
OCTINOXATE OCTINOXATE 0.03 g

Inactive Ingredients

Ingredient Name Strength
MICA
DIMETHICONE
MAGNESIUM STEARATE
ISOSTEARYL NEOPENTANOATE
.ALPHA.-TOCOPHEROL ACETATE
PHENOXYETHANOL
ALUMINUM OXIDE
TRIETHOXYCAPRYLYLSILANE
CAPRYLYL GLYCOL
CERAMIDE 3
CHLORPHENESIN
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
RED (Rose lightly yellowish)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:14783-057-01 10 in 1 CARTRIDGE
2 NDC:14783-057-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-05-27


LBEL

Titanium Dioxide, Zinc Oxide, and Octinoxate POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:14783-058
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
titanium dioxide 0.062393 g
Zinc Oxide Zinc oxide 0.049 g
OCTINOXATE OCTINOXATE 0.03 g

Inactive Ingredients

Ingredient Name Strength
MICA
DIMETHICONE
MAGNESIUM STEARATE
ISOSTEARYL NEOPENTANOATE
.ALPHA.-TOCOPHEROL ACETATE
PHENOXYETHANOL
ALUMINUM OXIDE
TRIETHOXYCAPRYLYLSILANE
CAPRYLYL GLYCOL
CERAMIDE 3
CHLORPHENESIN
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
BROWN (Beige)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:14783-058-01 10 in 1 CARTRIDGE
2 NDC:14783-058-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-05-27


LBEL

Titanium Dioxide, Zinc Oxide, and Octinoxate POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:14783-059
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
titanium dioxide 0.062393 g
Zinc Oxide Zinc oxide 0.049 g
OCTINOXATE OCTINOXATE 0.03 g

Inactive Ingredients

Ingredient Name Strength
MICA
DIMETHICONE
MAGNESIUM STEARATE
ISOSTEARYL NEOPENTANOATE
.ALPHA.-TOCOPHEROL ACETATE
PHENOXYETHANOL
ALUMINUM OXIDE
TRIETHOXYCAPRYLYLSILANE
CAPRYLYL GLYCOL
CERAMIDE 3
CHLORPHENESIN
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
BROWN (Yellowish Beige)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:14783-059-01 10 in 1 CARTRIDGE
2 NDC:14783-059-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-05-27


LBEL

Titanium Dioxide, Zinc Oxide, and Octinoxate POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:14783-060
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
titanium dioxide 0.062393 g
Zinc Oxide Zinc oxide 0.049 g
OCTINOXATE OCTINOXATE 0.03 g

Inactive Ingredients

Ingredient Name Strength
MICA
DIMETHICONE
MAGNESIUM STEARATE
ISOSTEARYL NEOPENTANOATE
.ALPHA.-TOCOPHEROL ACETATE
PHENOXYETHANOL
ALUMINUM OXIDE
TRIETHOXYCAPRYLYLSILANE
CAPRYLYL GLYCOL
CERAMIDE 3
CHLORPHENESIN
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
BROWN (Light Reddish Beige)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:14783-060-01 10 in 1 CARTRIDGE
2 NDC:14783-060-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-05-27


LBEL

Titanium Dioxide, Zinc Oxide, and Octinoxate POWDER

Product Information

Product Type Human otc drug label Item Code (Source) NDC:14783-061
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
titanium dioxide 0.062393 g
Zinc Oxide Zinc oxide 0.049 g
OCTINOXATE OCTINOXATE 0.03 g

Inactive Ingredients

Ingredient Name Strength
MICA
DIMETHICONE
MAGNESIUM STEARATE
ISOSTEARYL NEOPENTANOATE
.ALPHA.-TOCOPHEROL ACETATE
PHENOXYETHANOL
ALUMINUM OXIDE
TRIETHOXYCAPRYLYLSILANE
CAPRYLYL GLYCOL
CERAMIDE 3
CHLORPHENESIN
FERRIC OXIDE YELLOW
ferric oxide red
FERROSOFERRIC OXIDE

Product Characteristics

Color
BROWN (Reddish Beige)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:14783-061-01 10 in 1 CARTRIDGE
2 NDC:14783-061-02 1 in 1 BOX

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-05-27


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.